AIM ImmunoTech (AIM) Other Non Operating Income (2010 - 2026)

AIM ImmunoTech (AIM) has 11 years of Other Non Operating Income data on file, last reported at $8000.0 in Q1 2026.

• Quarterly Other Non Operating Income fell 27.27% year-over-year to $8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 45.94% YoY) and the FY2025 annual result came in at $3.2 million, down 38.69% from the prior year.
• Other Non Operating Income eased to $8000.0 in Q1 2026, from $7.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $7.2 million in Q4 2025 to a low of -$4.0 million in Q3 2025.
• A 5-year average of $641235.3 and a median of $172000.0 in 2022 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2024 — Other Non Operating Income soared 2089.92% — and 2025, when it slumped 653.9%.
• Tracing AIM's Other Non Operating Income over 5 years: stood at $333000.0 in 2022, then decreased by 22.52% to $258000.0 in 2023, then soared by 2089.92% to $5.6 million in 2024, then rose by 26.73% to $7.2 million in 2025, then tumbled by 99.89% to $8000.0 in 2026.
• The last three Other Non Operating Income figures came in at $8000.0 (Q1 2026), $7.2 million (Q4 2025), and -$4.0 million (Q3 2025), per Business Quant data.